Bayer – Global Home
At Bayer, we believe it´s possible to create a better world where health and nutrition are accessible to all, embodying our mission "Health for all, Hunger for none". As a global company with core competencies in health care and agriculture, we design our products and services to address the world´s greatest challenges and the most ...
Bayer’s Pharma Growth Strategy Progressing Well as Pipeline …
4 days ago · WHIPPANY, N.J., January 14, 2025 – On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple regulatory filing submissions underway for key growth drivers darolutamide, finerenone, and elinzanetant. "We are successfully delivering on our ambitious business goals despite significant ...
Health for all, Hunger for none | Bayer United States
Health for all, Hunger for none. It’s not only our mission, it’s what fuels each and every one of us, every single day. At Bayer, our commitment is to better the lives of all Americans – we’re finding groundbreaking solutions that help put food on our tables and offer innovations in self-care and medicine for all Americans so they can ...
拜耳中国 - bayer.com.cn
我们的产品正在帮助解决当今一些最严峻的挑战，其中包括全球人口增长、 老龄化社会以及高效--并在可能的情况下可持续--使用自然资源的需求。
拜耳大中华区 -拜耳中国 - bayer.com.cn
拜耳是一家具有150多年历史的创新企业，在生命科学领域的健康与营养方面具有核心竞争力。 拜耳致力于以创新的产品帮助解决当今人类社会所面临的一些重大挑战。 随着人类预期寿命不断延长，人口不断增长，拜耳通过专注于预防、缓解和治疗疾病的研发活动来改善人们的生活质量。 与此同时，拜耳通过突破性创新引领农业未来，帮助农户、消费者得到健康、安全、可负担的食物，并且生产过程对社区、对环境友好。 拜耳在中国的历史源远流长，早在1882年，拜耳公司首次 …
Bayer’s Pharma Growth Strategy Progressing Well as Pipeline …
4 days ago · WHIPPANY, N.J., January 14, 2025--On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with ...
拜耳医药保健有限公司 - 百度百科
拜耳医药保健是拜耳集团的子集团，总部位于德国的勒沃库森，主要研究开发、生产和销售用于预防、诊断和治疗疾病的原研产品，拜耳医药保健致力于提高人类及动物的健康水平。 2018年9月10日，荣获第十届“ 中华慈善奖 ”。 [1] 专业诊断系统和处方药共5个部门组成。 2005年拜耳医药保健全球销售额达94亿欧元。 2005年拜耳通过收购罗氏非处方药部门，拜耳已经跻身世界非处方药三强；拜耳医药的处方药部继续专注于 心血管病 、糖尿病、感染和泌尿系统等常用药物领 …
Bayer’s Pharma Growth Strategy Progressing Well as Pipeline …
5 days ago · With regulatory submissions under review around the world, Bayer anticipates a potential launch this year, aiming for fast market penetration building on Bayer's strength in women's healthcare. Elinzanetant is the first dual neurokinin-1 and 3 (NK-1 and 3) receptor antagonist with potential to transform the management of menopause, broadening ...
Bayer HealthCare Pharmaceuticals - Drugs.com
Aug 22, 2024 · Phone: (862) 404 3000 Website: https://www.bayer.us/ Careers: career.bayer.us/en Patient Assistance Program: www.drugs.com/manufacturer... Bayer HealthCare Pharmaceuticals Inc. manufactures, markets and/or distributes more than 23 drugs in the United States. Medications listed here may also be marketed under different names in different countries.
Women's Healthcare | Educational Resources | Bayer US Medical …
Explore Bayer’s educational resources on women's healthcare, such as contraception, HMB, and menopause. Learn more about Bayer publications and ongoing trial opportunities.